Show Notes
This week on One Thirty Biohacks, we sit down with Ajla Zenalagic — former HR leader and coach with a background in corporate development, who now helps individuals and organizations build stronger alignment between well-being, leadership, and human connection.
We explore the shift from performance to presence — and what it really takes to lead and live with more clarity, authenticity, and balance. Ajla shares her journey from the corporate world to holistic coaching, and how change often begins with the people most ready to shift — even when the system around them doesn’t evolve at the same pace.
We also discuss: • Why emotional honesty and self-leadership matter in high-pressure environments • How to value gender differences without falling into outdated roles • What happens when we stop controlling — and start connecting • How relational dynamics at work shape both culture and health
It’s an honest and insightful conversation about the future of work, and how we bring more humanity into the way we lead, communicate, and take care of ourselves.
Curious to learn more about our approach to corporate health? Come meet the One Thirty Labs team at TechBBQ, August 27–28, where we’ll be showcasing tools, insights, and experiences that support healthier, high-performing teams. Hosted on Acast. See acast.com/privacy for more information.
More from One Thirty Biohacks
Red light therapy is everywhere. From LED masks to full-body panels, the technology is becoming increasingly popular. But how much do we really know about how it works, and how can we tell which devices are worth investing in?
What if the problem with Ozempic isn’t the peptide, it’s the dose?
Why does a supplement work brilliantly for one person and do almost nothing for another?
What if the future of longevity isn’t just about living longer, but changing how we age?
Could stem cells change the way we approach healing and regeneration? In this episode, Dr. Torbjörn Ogéus explores the science of stem cells, their role in tissue repair and the emerging research into pluripotent cells in adult blood.